Hospital-Based Health Technology Assessment
Springer International Publishing (Verlag)
978-3-319-81842-9 (ISBN)
A timely work describing how localized hospital-based health technology assessment (HB-HTA) complements general, 'arms-length' HTA agency efforts, and what has been the collective global impact of HB-HTA across the globe. While HB-HTA has gained significant momentum over the past few years, expertise in the field, and information on the operation and organization of HB-HTA, has been scattered. This book serves to bring this information together to inform those who are currently working in the field of HTA at the hospital, regional, national or global level. In addition, this book is intended for decision-makers and policy-makers with a stake in determining the uptake and decommissioning of new and established technologies in the hospital setting.
HTA has traditionally been performed at the National/Regional level by HTA Agencies, typically linked to governments. Yet hospitals are the main entry door for most health technologies (HTs). Hospital decision-makers must undertake multiple high stakes investment and disinvestment decisions annually for innovative HTs, usually without adequate information. Despite the existence of arms-length HTA Agencies, inadequate information is available to hospital decision-makers either because relevant HTA reports are not yet released at the time of entry of new technologies to the field, or because even when the report exists, the information contained is insufficient to clarify the contextualized informational needs of hospital decision makers. Therefore, there has recently been a rising trend toward hospital-based HTA units and programs. These units/programs complement the work of National/Regional HTA Agencies by providing the key and relevant evidence needed by hospital decision makers in their specific hospital context, and within required decision-making timelines. The emergence of HB-HTA is creating a comprehensive HTA ecosystem across health care levels, which creates better bridges for knowledge translationthrough relevance and timeliness.
Laura is the Head of the Health Technology Assessment (HTA) Unit at the Hospital Clinic of Barcelona. She has over 20 years of experience in evaluative research, specifically in HTA. She also serves as chair of the HTAi Policy Forum. Previously, she has worked in the Catalan Ministry of Health and was the co-founder of the Catalan Agency per HTA. She has been the coordinator of the European Project AdHopHTA (Adopting Hospital based HTA). Her work has focused on the development, identification, management and transfer of information to advise on the designing of strategies and policies in the areas of assessment, planning and access of medical devices, drugs, surgical procedures and other health care technologies as well as health care programs. She has published 19 articles in national journals, 24 articles in international journals, 5 books chapters written, and 38 publications for governmental organizations related to HTA and planning. She serves as a member of the Editorial Committee of the international Journal for Health Technology Assessment. Dr. Janet Martin is Director of the Centre for Medical Evidence, Decision Integrity & Clinical Impact (MEDICI), and Assistant Professor, Departments of Anesthesia & Perioperative Medicine and Epidemiology & Biostatistics at the Schulich School of Medicine & Dentistry, Western University in London, Canada. Her research focuses on applied health technology assessment, evidence-informed decision making, and knowledge translation (HTA&KT) in hospital and regional settings. Her research also extends to hospitals and healthcare systems in developing countries to improve essential emergency and surgical services.
1. Introduction.- 2. Hospital-Based Health Technology Assessment: The Australian Experience.- 3. Hospital-Based HTA in China.- 4. Hospital-Based Health Technology Assessment (HTA) in New Zealand.- 5. Hospital-Based Health Technology Assessment in a Public-Sector Tertiary Hospital In Singapore.- 6. Hospital Based Health Technology Assessment In Denmark.- 7. Health Technology Assessment Activities in Finnish Hospitals.- 8. The ComitéD´Evaluationet de Diffusion des Technologiques (CEDIT).- 9. The HTA and Innovation Unit at Gemelli University Hospital.- 10. Hospital Based HTA at Radboud University Medical Centre in the Netherlands: Welcome to Reality.- 11. Hospital Based Health Technology Assessment in Three Spanish Hospitals.- 12. Activity-Based HTA: Hospital-Based HTA Performed by Clinicians With Support and Quality Control - The Sahlgrenska University Hospital HTA-Centrum Experience.- 13. Hospital HTA in Switzerland.- 14. Hospital Based HTA in Turkey.- 15. The Evidence Decision SupportProgram (EDSP) within the Surgery Strategic Clinical Network (SSCN) of Alberta Health Services (AHS).- 16. Hospital HTA and Know4Go at MEDICI in London, Ontario.- 17. Technology Assessment At Sick Kids (TASK): A Health Technology Assessment Research Unit Devoted to Child Health.- 18. Hospitalbased HTA at the Centre hospitalier de l'Université de Montréal.- 19. CHU de Québec - Université Laval: 10 Years Experience in HB-HTA.- 20. CHUS in Quebec.- 21. The Health Technology Assessment Unit (TAU) of the McGill University Health Centre (MUHC).- 22. The Penn Medicine Center for Evidence-Based Practice: Supporting the Quality, Safety and Value of Patient Care Through Evidence-Based Practice at the Systems Level.- 23. Medical Technology Assessment at Kaiser Permanente.- 24. Health Technology Assessment in aPublic Hospital in South Africa.- 25. Hospital Based HTA in Argentina: The Hospital Garrahanand Hospital El CruceExperience.- 26. The Role of Hospitals in Health Technology Assessment in Brazil.- 27. Networks In HB-HTA.- 28. View from Hospital Stake-Holders.- 29. View From Industry.- 30. Involving Patients In Hospital-Based HTA: Experiences, Approaches And Future Directions.- 31. View from Clinicians.- 32. Hospital Based HTA in 25 Organizations World-Wide: Lessons Learned.- 33. Looking to the Future of HB-HTA: The Next Frontier.
Erscheinungsdatum | 31.01.2023 |
---|---|
Zusatzinfo | XII, 397 p. 39 illus., 33 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 845 g |
Themenwelt | Mathematik / Informatik ► Informatik |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Pharmazie | |
Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
Technik | |
Schlagworte | affordability • Budget • contextualization • Disinvestment • Evidence-Based Decision-Making • Evidence Synthesis, Health Economics • Health Technologies • Impact • Innovation • Investment • knowledge translation • Multi-criteria decision analysis • Pharmacoeconomics • policy-making • Priority-Setting • Program evaluation |
ISBN-10 | 3-319-81842-2 / 3319818422 |
ISBN-13 | 978-3-319-81842-9 / 9783319818429 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich